THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,207 | -61.3% | 139,898 | -53.5% | 0.01% | -58.6% |
| Q2 2023 | $3,116 | -99.4% | 301,080 | +507.1% | 0.03% | +480.0% |
| Q3 2022 | $502,000 | +253.5% | 49,596 | +214.8% | 0.01% | +150.0% |
| Q2 2022 | $142,000 | -57.9% | 15,756 | -55.4% | 0.00% | 0.0% |
| Q1 2022 | $337,000 | -18.6% | 35,289 | -6.0% | 0.00% | 0.0% |
| Q4 2021 | $414,000 | +76.9% | 37,553 | +132.5% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | +17.0% | 16,150 | +64.3% | 0.00% | 0.0% |
| Q1 2021 | $200,000 | -35.7% | 9,830 | -53.4% | 0.00% | -77.8% |
| Q3 2020 | $311,000 | -12.4% | 21,083 | +24.5% | 0.01% | -18.2% |
| Q2 2020 | $355,000 | – | 16,928 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |